FDA Grants Orphan Drug Designation to Tigilanol Tiglate for

Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response.

Related Keywords

Intratumoral Tigilanol Tiglate , , Trial Name , Clinical Study , Soft Tissue ,